Discussion on the potential impact of microclots and the upcoming related events
-
Dr. Philip McMillan focused on COVID-19 and autoimmunity • 0:05
-
Autoimmune response triggered by specific proteins like ace2 • 0:21
-
Understanding the pandemic through a different angle • 0:35
-
Upcoming discussion on microclots and Spike detox • 1:12
-
Presentation on nitric oxide and humming as an important strategy • 1:46
-
25% of corpses in 2023 showed microclotting, a significant increase from pre-COVID times • 2:07
-
Questioning the mechanism behind the increase in microclots • 3:02
The discussion explores the prevalence and potential impact of microclots in the body, particularly in relation to long covid and other comorbidities
-
Microclots may be prevalent in a significant proportion of the population, even in seemingly healthy cohorts • 3:43
-
Specific comorbidities such as hypertension, high cholesterol, cardiovascular disease, and type 2 diabetes were found to be associated with microclots • 4:32
-
The balance of clotting in the body is crucial, as both excessive and insufficient clotting can lead to health issues • 5:24
-
The body has a system to prevent blood leakage when a blood vessel is broken, involving clotting mechanisms • 6:07
Explanation of microclots and their potential impact on clotting process and health complications
-
Platelets play a crucial role in clotting to prevent blood leakage • 6:14
-
Clots formed by platelets and fibrin help in healing process • 6:56
-
Complications can arise in individuals with clotting disorders • 7:06
-
Microclots may lead to uncontrolled clotting and health issues • 7:43
-
Potential presence of microclots in individuals prior to death • 8:15
-
Study examined characteristics of microclots and platelet function • 8:33
-
Platelet pore analysis was conducted to understand clotting process • 8:48
Significant findings of microclotting in patients, potential relevance to longer term disease, and the need for further research
-
Platelets were taken out to assess clotting, revealing significant microclotting in patients • 8:56
-
Abnormalities should not be ignored in clinical medicine • 10:03
-
Lack of relevant research on microclotting and circulating spike proteins • 10:31
-
Presentation slides and full video available for more detailed research findings • 10:41
-
Circulating spike proteins may be part of the microclotting picture • 11:30
The speaker discusses the formation of small blood clots and their potential impact on organ damage, emphasizing the need for proactive research and collaboration in understanding the disease trajectory
-
Formation of small microclots and their potential impact on major organs • 11:46
-
Uncertainty regarding the role of Spike protein in driving disease • 11:54
-
Need for proactive approach in addressing abnormal patterns and excess deaths • 12:25
-
Importance of understanding the combination of factors leading to disease presentation • 12:42
-
Current lack of full understanding of disease trajectory and the need for further research • 13:06